| Characteristic | Percentage of total segment revenue |
|---|---|
| Established markets | 74% |
| Emerging growth markets | 26% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
February 2026
More information
Region
Worldwide
Survey time period
2025
Supplementary notes
Net sales from continuing operations by location of customer. Emerging growth markets comprise all markets other than the established markets of the US, Canada, Western
Europe, Japan, Australia and New Zealand. Novartis definition of Western Europe includes Austria, Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg,
Malta, The Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Percentages calculated based on given sales figures.
Citation formats
